Desert_Power
Footballguy
This isn't what I read before, but in the vein of what I saw:Not doubting you, but this seems hard to believe. If annual flu shots are profitable, why not annual covid shots? Or flu-covid combos? I understand that mRNA vaccines are probably more costly to manufacture than flu shots, but it seems like a pretty obvious +EV move for insurance companies.
Jha said the FDA will likely adopt redesigned vaccines this summer that target mutations the virus has developed over the past two years, with the aim of giving people more durable protection against Covid. However, he said the U.S. would only have the money to provide those next-generation shots for people at high risk of severe disease, the elderly and immune compromised, if Congress doesn’t provide money. The U.S. would also run out of treatments for people who get infected, he said.
https://www.cnbc.com/2022/05/18/covid-us-faces-unnecessary-deaths-if-congress-fails-to-pass-funding-bill.html
You can also find articles like this out there (not sure the reliability): https://www.fiercepharma.com/pharma/another-covid-19-manufacturing-partner-time-pfizers-biovac-warns-production-slump-amid-low
So it sounds like they will be producing them, but it is uncertain if the US will have a full supply? Assume tests and antivirals would follow similar paths. Apologies for sharing a comment without being able to source where I read it, but curious what the rest of y'all can dig up. It is a notoriously hard subject to search.